These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 25784380)
1. Biologic basis of osteoarthritis: state of the evidence. Malemud CJ Curr Opin Rheumatol; 2015 May; 27(3):289-94. PubMed ID: 25784380 [TBL] [Abstract][Full Text] [Related]
2. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Bondeson J; Wainwright SD; Lauder S; Amos N; Hughes CE Arthritis Res Ther; 2006; 8(6):R187. PubMed ID: 17177994 [TBL] [Abstract][Full Text] [Related]
3. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Woolley DE; Tetlow LC Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391 [TBL] [Abstract][Full Text] [Related]
4. The role of cytokines in osteoarthritis pathophysiology. Fernandes JC; Martel-Pelletier J; Pelletier JP Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286 [TBL] [Abstract][Full Text] [Related]
5. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270 [TBL] [Abstract][Full Text] [Related]
6. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663 [TBL] [Abstract][Full Text] [Related]
7. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis. Hartgring SA; van Roon JA; Wenting-van Wijk M; Jacobs KM; Jahangier ZN; Willis CR; Bijlsma JW; Lafeber FP Arthritis Rheum; 2009 Sep; 60(9):2595-605. PubMed ID: 19714586 [TBL] [Abstract][Full Text] [Related]
8. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. van Kuijk AW; Reinders-Blankert P; Smeets TJ; Dijkmans BA; Tak PP Ann Rheum Dis; 2006 Dec; 65(12):1551-7. PubMed ID: 16728461 [TBL] [Abstract][Full Text] [Related]
9. SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance. Niederer F; Ospelt C; Brentano F; Hottiger MO; Gay RE; Gay S; Detmar M; Kyburz D Ann Rheum Dis; 2011 Oct; 70(10):1866-73. PubMed ID: 21742641 [TBL] [Abstract][Full Text] [Related]
11. Metabolic triggered inflammation in osteoarthritis. Wang X; Hunter D; Xu J; Ding C Osteoarthritis Cartilage; 2015 Jan; 23(1):22-30. PubMed ID: 25452156 [TBL] [Abstract][Full Text] [Related]
12. The expression of proinflammatory cytokines and matrix metalloproteinases in the synovial membranes of patients with osteoarthritis compared with traumatic knee disorders. Wassilew GI; Lehnigk U; Duda GN; Taylor WR; Matziolis G; Dynybil C Arthroscopy; 2010 Aug; 26(8):1096-104. PubMed ID: 20678708 [TBL] [Abstract][Full Text] [Related]
13. The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis. Pierer M; Brentano F; Rethage J; Wagner U; Hantzschel H; Gay RE; Gay S; Kyburz D Rheumatology (Oxford); 2007 Jul; 46(7):1063-70. PubMed ID: 17426140 [TBL] [Abstract][Full Text] [Related]
14. Chondroprotective and anti-inflammatory effects of S-methylisothiourea, an inducible nitric oxide synthase inhibitor in cartilage and synovial explants model of osteoarthritis. Balaganur V; Pathak NN; Lingaraju MC; More AS; Latief N; Kumari RR; Kumar D; Tandan SK J Pharm Pharmacol; 2014 Jul; 66(7):1021-31. PubMed ID: 24697299 [TBL] [Abstract][Full Text] [Related]
15. Inflammatory mediators in osteoarthritis: A critical review of the state-of-the-art, current prospects, and future challenges. Rahmati M; Mobasheri A; Mozafari M Bone; 2016 Apr; 85():81-90. PubMed ID: 26812612 [TBL] [Abstract][Full Text] [Related]
16. Articular ankle fracture results in increased synovitis, synovial macrophage infiltration, and synovial fluid concentrations of inflammatory cytokines and chemokines. Furman BD; Kimmerling KA; Zura RD; Reilly RM; Zlowodzki MP; Huebner JL; Kraus VB; Guilak F; Olson SA Arthritis Rheumatol; 2015 May; 67(5):1234-9. PubMed ID: 25707992 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory cytokines and cellular metabolites as synovial fluid biomarkers of posttraumatic ankle arthritis. Adams SB; Nettles DL; Jones LC; Miller SD; Guyton GP; Schon LC Foot Ankle Int; 2014 Dec; 35(12):1241-9. PubMed ID: 25201328 [TBL] [Abstract][Full Text] [Related]
18. Osteoarthritis: a tale of three tissues. Samuels J; Krasnokutsky S; Abramson SB Bull NYU Hosp Jt Dis; 2008; 66(3):244-50. PubMed ID: 18937640 [TBL] [Abstract][Full Text] [Related]
19. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Volck B; Johansen JS; Stoltenberg M; Garbarsch C; Price PA; Ostergaard M; Ostergaard K; Løvgreen-Nielsen P; Sonne-Holm S; Lorenzen I Osteoarthritis Cartilage; 2001 Apr; 9(3):203-14. PubMed ID: 11300743 [TBL] [Abstract][Full Text] [Related]
20. CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes. Zhu P; Lu N; Shi ZG; Zhou J; Wu ZB; Yang Y; Ding J; Chen ZN Arthritis Res Ther; 2006; 8(2):R44. PubMed ID: 16507143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]